140 related articles for article (PubMed ID: 2601252)
1. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
Michelacci YM; Glashan RQ; Schor N
Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
[TBL] [Abstract][Full Text] [Related]
2. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
Shum DK; Gohel MD
Clin Sci (Lond); 1993 Jul; 85(1):33-9. PubMed ID: 8149691
[TBL] [Abstract][Full Text] [Related]
3. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
Ryall RL; Harnett RM; Hibberd CM; Mazzachi BC; Mazzachi RD; Marshall VR
Br J Urol; 1987 Dec; 60(6):480-8. PubMed ID: 3427328
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycans in urolithiasis.
Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
[TBL] [Abstract][Full Text] [Related]
5. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
Gohel MD; Shum DK; Tam PC
Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
[TBL] [Abstract][Full Text] [Related]
7. Urinary glycosaminoglycan excretion in healthy and stone-forming children.
Harangi F; Györke Z; Melegh B
Pediatr Nephrol; 1996 Oct; 10(5):555-8. PubMed ID: 8897554
[TBL] [Abstract][Full Text] [Related]
8. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.
Dissayabutra T; Kalpongnukul N; Chindaphan K; Srisa-Art M; Ungjaroenwathana W; Kaewwongse M; Iampenkhae K; Tosukhowong P
PLoS One; 2019; 14(3):e0213180. PubMed ID: 30845174
[TBL] [Abstract][Full Text] [Related]
9. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
[TBL] [Abstract][Full Text] [Related]
10. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
Suzuki K; Mayne K; Doyle IR; Ryall RL
Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
[TBL] [Abstract][Full Text] [Related]
11. Urinary glycosaminoglycan excretion in urolithiasis.
Akçay T; Konukoğlu D; Dínçer Y
Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of 24-hour urinary excretion of glycosaminoglycans by renal stone formers and healthy adults.
Sidhu H; Hemal AK; Thind SK; Nath R; Vaidyanathan S
Eur Urol; 1989; 16(1):45-7. PubMed ID: 2714317
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans and oxalocalcic urolithiasis.
Grases F; Llompart I; Conte A; Coll R; March JG
Nephron; 1994; 68(4):449-53. PubMed ID: 7870230
[TBL] [Abstract][Full Text] [Related]
14. Does urine from stone-formers contain macromolecules which promote the crystal growth rate of calcium oxalate crystals in vitro?
Gjaldbaek JC; Robertson WG
Clin Chim Acta; 1980 Nov; 108(1):75-80. PubMed ID: 6778638
[TBL] [Abstract][Full Text] [Related]
15. Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.
Akinci M; Esen T; Koçak T; Ozsoy C; Tellaloğlu S
Eur Urol; 1991; 19(3):240-3. PubMed ID: 1649759
[TBL] [Abstract][Full Text] [Related]
16. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers.
Nikkilä MT
Urol Int; 1989; 44(3):157-9. PubMed ID: 2749930
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycans content of stone matrix.
Roberts SD; Resnick MI
J Urol; 1986 May; 135(5):1078-83. PubMed ID: 3959234
[TBL] [Abstract][Full Text] [Related]
18. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
Ombra MN; Casula S; Biino G; Maestrale G; Cardia F; Melis P; Pirastu M
Urology; 2003 Sep; 62(3):416-20. PubMed ID: 12946738
[TBL] [Abstract][Full Text] [Related]
19. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
20. The urinary response to an oral oxalate load in recurrent calcium stone formers.
Krishnamurthy MS; Hruska KA; Chandhoke PS
J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
